Plunkett Research Online: VolitionRX Ltd

VOLITIONRX LTD (VNRX:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Volition RX, Ltd. manufactures epigenetic cancer detection blood tests. The company's tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types......



VolitionRX Ltd
Ticker: VNRX
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax: 65-6333-7235
Address: 1 Scotts Road
No 24-05 Shaw Centre
Singapore, 228208 Singapore

Types Of Business
Industry Ranks

Industry NAICS code:

In-Vitro Diagnostic Substance Manufacturing
ContactsDescription
Cameron ReynoldsCEO/CEO, Subsidiary/Director/President
David VanstonCFO/Treasurer
See More
Volition RX, Ltd. manufactures epigenetic cancer detection blood tests. The company's tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types......See More See More

Auditor: Sadler,Gibb and Associates, LLC
Legal Advisor: Carrillo Huettel LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: